Key facts
- Notable investors include SOSV, Draper Associates, IndieBio, Arben Ventures, Outset Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Klona Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Klona Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Klona Biotech
Developer of a biotechnology company designed to revolutionize bioprinting with structural bio-integrated textiles for regenerative medicine and tissue engineering. The company offers new methods for rapid and scalable production of biological structures to fabricate structurally sound, patient-specific biological implants and accelerate pre-clinical testing and regulatory validation, enabling hospitals to have safe and reliable patient-specific organs that can be printed on demand.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Website
- klonabiotech.com/
- Ownership
- Privately Held (backing)
Klona Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Klona Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Klona Biotech in its N-PORT filings yet. We sweep new filings monthly.